Controlled-Release Dosage Forms for Diltiazem Hydrochloride

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-04-02-2004
Volume 28
Issue 4

The authors investigate whether an extrusion-spheronization proces can be used to develop a matrix-based, controlled-release formulation for a highly water-soluble drug.

External Link - article-91088.pdf

Articles in this issue
Spotlight on Business Risk
Vibration Technology for Active Dry-Powder Inhalers
In the Spotlight April 2004
FDA Attacks Counterfeits
Synthetic Excipients Challenge All-Natural Organics
April 2004
Controlled-Release Dosage Forms for Diltiazem Hydrochloride
Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Related Content
Magnified View of Lipid Nanoparticles | Image Credit: ©Aniwat - stock.adobe.com

Organic Nanoparticle-Based Drug-Delivery Systems as Alternatives to Lipid Nanoparticles

Cynthia A. Challener
March 9th 2025
Article

Exosomes, polymeric nanoparticles, and DNA nanostructures offer many potential advantages.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com

Pushing Tech Boundaries

Mike Hennessy Jr.
March 3rd 2025
Article

Artificial intelligence, among other technological advances, is pushing innovation boundaries.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Rare Disease Day Celebrated on February 28

Patrick Lavery
March 1st 2025
Article

More than 6000 rare diseases—those which affect fewer than one in 2000 people each—are acknowledged in the medical community, with 72% of them being genetic.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Rare Disease Day 2025: Pharmaceutical Treatments Advancing in the US, EU

Patrick Lavery
February 28th 2025
Article

Regulatory clearances and approvals continue as agencies work to disseminate literature, raise awareness, redouble research efforts, and improve the efficacy of clinical trials.